Milan, Italy

Amedeo Leonardo

This inventor holds 1 USPTO granted patent. Top assignee: Recordati S.a. Chemical and Pharmaceutical Company. Active years: 1990.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Amedeo Leonardo: Innovator in Pharmaceutical Chemistry

Introduction

Amedeo Leonardo is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel antihypertensive agents. His work has implications for the treatment of hypertension and related cardiovascular conditions.

Latest Patents

Amedeo Leonardo holds a patent for "Novel asymmetric diesters of 1,4-dihydro-2,6-dimethylpyridine-3,5-dicarboxylic acid." This innovative compound has the potential to serve as an effective antihypertensive and coronary dilating agent. The patent describes a general formula for these diesters, which can be synthesized from specific aldehydes and esters, showcasing Leonardo's expertise in chemical synthesis.

Career Highlights

Leonardo is associated with Recordati S.a., a prominent chemical and pharmaceutical company. His work at Recordati has allowed him to focus on developing new therapeutic agents that can improve patient outcomes in cardiovascular health. His dedication to research and innovation has positioned him as a key figure in his field.

Collaborations

Amedeo has collaborated with esteemed colleagues such as Giorgio Bianchi and Dante Nardi. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical products.

Conclusion

Amedeo Leonardo's contributions to pharmaceutical chemistry, particularly through his innovative patent, highlight his role as a leading inventor in the industry. His work continues to influence the development of effective treatments for hypertension and cardiovascular diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…